Skip Navigation



Carcinogenesis Advance Access published online on September 3, 2004

Carcinogenesis, doi:10.1093/carcin/bgh275
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/1/177    most recent
bgh275v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wallerand, H.
Right arrow Articles by Chopin, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallerand, H.
Right arrow Articles by Chopin, D. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received July 8, 2004
Revised August 20, 2004
Accepted August 24, 2004

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens

Hervé Wallerand 1, Ashraf A. Bakkar 1, Sixtina Gil Diez de Medina 1, Jean-Claude Pairon 1, Yu-Ching Yang 2, Dimitri Vordos 1, Hugues Bittard 3, Sylvie Fauconnet 3, Jean-Claude Kouyoumdjian 1, Marie-Claude Jaurand 1, Zuo-Feng Zhang 2, François Radvanyi 4, Jean-Paul Thiery 4, and Dominique K. Chopin 1*

1 EMI INSERM 03-37 and Service d'Urologie, Université Paris XII, AP-HP, Hôpital Henri Mondor, 94000 Créteil - France
2 Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA 90095-1772, USA
3 Service D'Urologie CHRU Besançon - France
4 UMR-144, CNRS - Institut Curie, 75005 Paris - France

* To whom correspondence should be addressed.


   Abstract

Smoking is a major risk factor for urothelial cell carcinoma (UCC) of the bladder. Mutations in FGFR3 and TP53 have been shown to define two distinct pathways in superficial papillary and invasive UCC disease, respectively. We investigated the relationship between smoking and these mutations by means of Denaturing High Performance Liquid Chromatography and sequencing for 110 primary UCC of the bladder. This study included 48 current smokers, 31 ex-smokers and 31 non-smokers. Thirty-five of the tumors were of stage pTa, 40 pT1 and 35 ≥pT2. Fourteen of the tumors were grade 1, 37 were grade 2 and 59 grade 3.

Smoking was associated with high-stage (p=0.03) and high-grade tumors (p=0.006). Twenty-two of the 110 tumors studied harbored TP53 mutations (20%) and 43 harbored FGFR3 mutations (39%). Odds ratios were higher for TP53 mutations in current smokers (OR, 2.25; 95% CI, 0.65-7.75) and ex-smokers (OR, 1.62; 95% CI, 0.41-6.42) than in non-smokers. Double TP53 mutations and A:T>G:C TP53 mutation patterns were found only in current smokers. Patients with the FGFR3wildtype/TP53mutated genotype had significantly higher levels of tobacco consumption, as measured in pack-years (p=0.01). Smoking influenced neither the frequency nor the pattern of FGFR3 mutations.

Our results suggest that smoking is associated with invasive and high-grade UCCs, at initial presentation, and influenced TP53 or the molecular pathway defined by these mutations. In contrast, FGFR3 mutations are not affected by smoking and probably result from endogenous alterations. These data have potential implications for clinical management and prevention strategies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
R.A. Crallan, N.T. Georgopoulos, and J. Southgate
Experimental models of human bladder carcinogenesis
Carcinogenesis, March 1, 2006; 27(3): 374 - 381.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Knowles
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
Carcinogenesis, March 1, 2006; 27(3): 361 - 373.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.